Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-25

Clinical Trial Update: Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the TAH combination with Telmisartan/Amlodipine in essential hypertension to assess efficacy and safety; the study status is completed. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAH
  • Telmisartan/Amlodipine (telmisartan and amlodipine)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED